Syros PharmaceuticalsSYRS
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 65 institutions reported holding Syros Pharmaceuticals Inc. (SYRS) in their 13F filings, down 5 from Q2 2024. 10 opened new positions and 17 sold out. The largest holders were Bain Capital Life Sciences Investors, LLC ($5.9M), Siren, L.L.C. ($5.6M) and Adage Capital Partners Gp, L.L.C. ($4.5M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Syros Pharmaceuticals Inc.
- CUSIP
- 87184Q206
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $414K |
| Exits | 17 | $18.7M |
All 13F filers, Q2 2024 → Q3 2024: 764,387 shares bought and 4,791,873 shares sold, net −4,027,486 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 65 holders
| Bain Capital Life Sciences Investors, LLC | 0.62% | Add +0.0% | 2,750,151 | $5.9M |
| Siren, L.L.C. | 0.28% | — | 2,587,372 | $5.6M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | No change | 2,071,914 | $4.5M |
| Samsara Biocapital, LLC | 0.74% | No change | 1,786,427 | $3.8M |
| Point72 Asset Management | 0.01% | No change | 1,471,771 | $3.2M |
| Flagship Pioneering, LLC | 0.47% | No change | 1,293,849 | $2.8M |
| Avidity Partners Management LP | 0.12% | Reduce -36.5% | 1,063,000 | $2.3M |
| Vanguard Group Inc. | 0.00% | Reduce -1.5% | 953,313 | $2.0M |
| Deep Track Capital, LP | 0.06% | No change | 828,485 | $1.8M |
| Opaleye Management Inc. | 0.24% | Reduce -24.3% | 654,943 | $1.4M |
| Blue Owl Capital Holdings LP | 0.22% | Add +51.3% | 515,855 | $1.1M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | Add +29.2% | 359,305 | $773K |
| ExodusPoint Capital Management, LP | 0.01% | Add +18.7% | 313,004 | $673K |
| Exome Asset Management LLC | 0.43% | Add +87.6% | 298,575 | $642K |
| BlackRock, Inc. | 0.00% | — | 261,579 | $562K |
| Omega Fund Management, LLC | 0.34% | No change | 251,270 | $540K |
| Geode Capital Management, LLC | 0.00% | Reduce -9.5% | 204,695 | $440K |
| Marshall Wace, LLP | 0.00% | No change | 160,390 | $345K |
| Perceptive Advisors LLC | 0.01% | No change | 116,754 | $251K |
| Renaissance Technologies | 0.00% | Reduce -17.9% | 96,435 | $207K |
| Prelude Capital Management, LLC | 0.01% | Add +121.1% | 89,097 | $192K |
| Walleye Capital LLC | 0.00% | Reduce -69.7% | 86,641 | $186K |
| Qube Research & Technologies Ltd | 0.00% | Add +176.0% | 77,716 | $167K |
| State Street Corp. | 0.00% | No change | 69,430 | $149K |
| Acadian Asset Management LLC | 0.00% | Add +52.9% | 52,866 | $113K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 51,500 | $111K |
| Pale Fire Capital SE | 0.02% | New | 49,211 | $106K |
| ADAR1 Capital Management, LLC | 0.02% | New | 45,000 | $97K |
| Northern Trust Corp. | 0.00% | No change | 40,812 | $88K |
| 1492 Capital Management LLC | 0.04% | No change | 39,244 | $84K |
| Millennium Management | 0.00% | Reduce -49.7% | 31,700 | $68K |
| Certuity, LLC | 0.01% | Add +40.7% | 29,825 | $64K |
| XTX Topco Ltd | 0.00% | New | 28,834 | $62K |
| Two Sigma Investments, LP | 0.00% | Reduce -29.3% | 28,475 | $61K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 22,550 | $49K |
| Virtu Financial LLC | 0.00% | New | 19,629 | $42K |
| Clarius Group, LLC | 0.00% | No change | 18,620 | $40K |
| UBS Group AG | 0.00% | Reduce -22.4% | 16,728 | $36K |
| Gsa Capital Partners LLP | 0.00% | New | 15,905 | $34K |
| HighTower Advisors, LLC | 0.00% | Reduce -2.9% | 14,898 | $32K |
| Marex Group Ltd | 0.00% | New | 12,700 | $27K |
| Corient Private Wealth LP | 0.00% | No change | 12,000 | $26K |
| Centerpoint Advisors, LLC | 0.01% | New | 10,659 | $23K |
| Wiser Wealth Management, Inc | 0.01% | New | 10,000 | $22K |
| Integrated Wealth Concepts LLC | 0.00% | No change | 10,000 | $22K |
| Aster Capital Management (DIFC) Ltd | 0.00% | — | 9,970 | $21K |
| Group One Trading LLC | 0.00% | Add +19.3% | 7,634 | $16K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 4,500 | $10K |
| Morgan Stanley | 0.00% | Reduce -75.3% | 2,392 | $5K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 1,095 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,032 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -67.8% | 1,100 | $2K |
| Russell Investments Group, Ltd. | 0.00% | No change | 750 | $2K |
| Bank of America Corp. | 0.00% | Reduce -96.1% | 705 | $2K |
| Citigroup Inc. | 0.00% | New | 687 | $1K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -84.7% | 595 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 549 | $1K |
| Wells Fargo & Company | 0.00% | No change | 454 | $976 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -91.4% | 246 | $529 |
| Fifth Third Bancorp | 0.00% | No change | 129 | $277 |
| Activest Wealth Management | 0.00% | No change | 87 | $187 |
| Sound Income Strategies, LLC | 0.00% | No change | 76 | $163 |
| PSI Advisors, LLC | 0.00% | No change | 13 | $28 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8 | $17 |
| FMR LLC | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is SYRS's weight in each manager's 13F, not the share of Syros Pharmaceuticals Inc. the manager owns.